Focused screening reveals functional effects of microRNAs differentially expressed in colorectal cancer

Danuta Sastre1,2, João Baiochi2, Ildercilio Mota de Souza Lima2

  • 1Laboratory of Human and Medical Genetics, Federal University of Pará, Rua Augusto Corrêa, 01. Guamá., Belém, Pará, CEP 66075-110, Brazil.

BMC Cancer
|December 23, 2019
PubMed
Abstract

Insights

MicroRNAs poorly expressed in colorectal cancer (CRC) can halt proliferation and induce cell death. MiR-101-3p preferentially inhibits anti-apoptotic MCL-1, activating intrinsic apoptosis and offering potential CRC therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Colorectal cancer (CRC) remains a significant global health burden.
  • MicroRNAs play a crucial role in cancer development (carcinogenesis).
  • Aberrant microRNA expression is observed in CRC tissues and patient serum, necessitating functional exploration.

Purpose of the Study:

  • To investigate the cellular effects of microRNAs aberrantly expressed in CRC.
  • To determine the impact of specific microRNAs on colorectal cancer cell proliferation and death.

Main Methods:

  • Transfection of 31 microRNA mimics into HCT116 colorectal cancer cells.
  • High-content screening (HCS) to quantify cell viability and apoptosis.
  • Analysis of apoptotic pathways (intrinsic and extrinsic) and gene expression (microarray, qPCR, Western blot).

Main Results:

  • Twenty microRNAs modulated HCT116 cell proliferation; miR-22-3p, miR-24-3p, and miR-101-3p significantly repressed proliferation and induced cell death.
  • These anti-proliferative microRNAs were previously found to be downregulated in CRC samples.
  • miR-101-3p preferentially downregulated the anti-apoptotic MCL-1 long isoform, activating intrinsic apoptosis and reducing stemness-associated genes (IL6ST, STAT3A/B, MYC).

Conclusions:

  • MicroRNAs upregulated in CRC tend to promote proliferation, while those downregulated inhibit proliferation and induce cell death.
  • miR-101-3p's anti-tumoral activity is linked to preferential inhibition of MCL-1 long isoform, activating intrinsic apoptosis.
  • This mechanism likely involves the inhibition of the IL-6/JAK/STAT signaling pathway.